Depression Mental and Behavioural Disorders
Conditions
Interventions
Current intervention as of 21/01/2022:
This is a multi-site cluster randomised controlled trial.
We will seek patients who are currently receiving care for chronic depression within mental health serv
Sponsors
East London NHS Foundation Trust
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: Current participant inclusion criteria as of 21/01/2022: Clinician Participants 1. Qualification as a mental health or healthcare professional (including Band 4 Support Workers, Social Workers and Occupational Therapists) 2. Experience of working in a healthcare setting for at least 6 months 3. Currently (or within the last 6 months) treated individuals with chronic depression 4. Have at least 4 patients with chronic depression on their caseload, or have the ability to ‘case swap’ with other team members, and seeing these patients regularly (e.g. once a month) 5. No plans to leave their post within the next 6 months Patient Participants 1. 18-100 years old 2. Exhibiting symptoms of depression or non-psychotic low mood with a duration of illness of at least 2 years (can be co-morbid with other conditions such as anxiety, personality disorder etc.) 3. Receiving treatment from an NHS mental health service with regular contact with clinicians 4. Capacity to provide informed consent 5. Ability to speak and understand English Previous participant inclusion criteria: Clinician Participants 1. Qualification as a mental health or healthcare professional (including Band 4 Support Workers, Social Workers and Occupational Therapists) 2. Experience of working in a healthcare setting for at least 6 months 3. Currently (or within the last 6 months) treated individuals with chronic depression 4. Have at least 4 patients with chronic depression on their caseload, or have the ability to ‘case swap’ with other team members, and seeing these patients regularly (e.g. once a month) 5. No plans to leave their post within the next 6 months Patient Participants 1. 18-80 years old 2. Exhibiting symptoms of depression or non-psychotic low mood with a duration of illness of at least 2 years (can be co-morbid with other conditions such as anxiety, personality disorder etc.) 3. Receiving treatment from an NHS mental health service with regular contact with clinicians 4. Capacity to provide informed consent 5. Ability to speak and understand English
Exclusion criteria
Exclusion criteria: Clinician Participants 1. Do not have at least 4 eligible patients on their caseload. 2. Do not have any frequent clinical contact with eligible patients. Patient Participants 1. Primary diagnosis of a substance misuse problem (F10 - F19). 2. Diagnosis of an organic, including symptomatic, mental disorder (F00-F09) e.g. Alzheimer's. 3. Inpatient on a psychiatric ward at the time of recruitment. 4. Does not have current clinical contact with a mental health professional.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life, as measured on the Manchester Short Assessment of Quality of Life (MANSA), 12 months after randomisation | — |
Secondary
| Measure | Time frame |
|---|---|
| The following measures are all collected at baseline, 6 months, and 12 months: 1. Depression symptoms, measured by two scales, the Montgomery–Samberg Depression Rating Scale (MADRS; observer rated) and Beck Depression Inventory (BDI-II; self-report*) 2. Severity of illness, will be measured by the Clinical Global Impression scale (CGI-I, clinician rated) 3 Economic evaluation through completion of the ICECAP-A (a measure of capability for the general adult population) 4. Satisfaction with care, measured using the Client Satisfaction Questionnaire (CSQ-8) 5. Health-related quality of life, measured using the Europol 5 dimension (EQ-5D-35L) 6. Data on health service usage in the past 6 months by the participant, collected via an amended version of the Client Service Receipt Inventory (CSRI). *The MANSA and the BDI-II will also be collected at 3 months. Additionally, those participants allocated to receive DIALOG+ will be given an additional questionnaire to measure their experience of receiving the DIALOG+ intervention. This is a specially designed questionnaire developed in partnership with the TACK Lived Experience Advisory Panel. This questionnaire will be completed at 6 months add 12 months. | — |
Countries
England, United Kingdom
Contacts
Public ContactVictoria Bird
Outcome results
None listed